Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terje Steigen

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Open Heart|June 7, 2019
Predictors of early mortality after transcatheter aortic valve implantationDidrik Kjønås, Gry Dahle, Henrik Schirmer, et al.
European Heart Journal. Acute Cardiovascular Care|December 20, 2017
Trends in clinical outcomes and survival following prehospital thrombolytic therapy given by ambulance clinicians for ST-elevation myocardial infarction in rural sub-arctic NorwayJan Mannsverk, Terje Steigen, Harald Wang, et al.
The New England Journal of Medicine|March 15, 2006
Homocysteine lowering and cardiovascular events after acute myocardial infarctionKaare Harald Bønaa, Inger Njølstad, Per Magne Ueland, et al.
Open Heart|January 16, 2026
Prognostic value of N-terminal pro-B-type natriuretic peptide and C reactive protein testing in patients with acute ST-segment elevation myocardial infarctionIoana Mihaela Dregoesc, Dana Cramariuc, Tom Wilsgaard, et al.
Plos One|March 4, 2021
Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT)Per-Jostein Samuelsen, Anne Elise Eggen, Terje Steigen, et al.
European Heart Journal|May 25, 2026
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction populationAnna Meta Dyrvig Kristensen, Jarle Jortveit, Therese Holmager, et al.
American Heart Journal|December 12, 2018
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Vidar Ruddox, Sigrun Halvorsen, et al.
Cardiology|April 13, 2021
Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Trial SubstudyTerje Steigen, Niels Ramsing Holm, Truls Myrmel, et al.
The New England Journal of Medicine|August 31, 2016
Drug-Eluting or Bare-Metal Stents for Coronary Artery DiseaseKaare H Bønaa, Jan Mannsverk, Rune Wiseth, et al.
Lancet (London, England)|April 5, 2026
Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trialEmil Nielsen Holck, Niels R Holm, David Hildick-Smith, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Open Heart|June 7, 2019
Predictors of early mortality after transcatheter aortic valve implantationDidrik Kjønås, Gry Dahle, Henrik Schirmer, et al.
European Heart Journal. Acute Cardiovascular Care|December 20, 2017
Trends in clinical outcomes and survival following prehospital thrombolytic therapy given by ambulance clinicians for ST-elevation myocardial infarction in rural sub-arctic NorwayJan Mannsverk, Terje Steigen, Harald Wang, et al.
The New England Journal of Medicine|March 15, 2006
Homocysteine lowering and cardiovascular events after acute myocardial infarctionKaare Harald Bønaa, Inger Njølstad, Per Magne Ueland, et al.
Open Heart|January 16, 2026
Prognostic value of N-terminal pro-B-type natriuretic peptide and C reactive protein testing in patients with acute ST-segment elevation myocardial infarctionIoana Mihaela Dregoesc, Dana Cramariuc, Tom Wilsgaard, et al.
Plos One|March 4, 2021
Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT)Per-Jostein Samuelsen, Anne Elise Eggen, Terje Steigen, et al.
European Heart Journal|May 25, 2026
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction populationAnna Meta Dyrvig Kristensen, Jarle Jortveit, Therese Holmager, et al.
American Heart Journal|December 12, 2018
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Vidar Ruddox, Sigrun Halvorsen, et al.
Cardiology|April 13, 2021
Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Trial SubstudyTerje Steigen, Niels Ramsing Holm, Truls Myrmel, et al.
The New England Journal of Medicine|August 31, 2016
Drug-Eluting or Bare-Metal Stents for Coronary Artery DiseaseKaare H Bønaa, Jan Mannsverk, Rune Wiseth, et al.
Lancet (London, England)|April 5, 2026
Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trialEmil Nielsen Holck, Niels R Holm, David Hildick-Smith, et al.
Pageof 3